Lipus (Lovastatin)

Lovastatin is used to treat disorders of lipid metabolism and to reduce cardiovascular risk.

• Hypercholesterolemia: reduces total and LDL cholesterol levels, helping to achieve target lipid goals.
• Primary hyperlipidemia: lowers elevated plasma lipids, improving lipid profile in patients with familial or secondary dyslipidemia.
• Prevention of cardiovascular disease: decreases risk of myocardial infarction and stroke by managing cholesterol in at‑risk individuals.

• Lovastatin competitively inhibits HMG‑CoA reductase, the key enzyme that catalyzes the conversion of HMG‑CoA to mevalonate, an early step in hepatic cholesterol biosynthesis. By blocking this pathway, intracellular cholesterol synthesis declines, leading to up‑regulation of LDL receptors on hepatocytes and increased clearance of circulating LDL‑cholesterol from the bloodstream. The reduction in hepatic cholesterol also stimulates synthesis of apolipoprotein B‑containing lipoproteins to a lesser extent, further contributing to lower plasma LDL concentrations.

Lovastatin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Headache: mild to moderate head pain.
• Indigestion: gastrointestinal discomfort or dyspepsia.
• Muscle aches: mild myalgia without weakness.

Serious or Rare Side Effects

• Rhabdomyolysis: severe muscle breakdown that can cause kidney injury.
• Severe liver injury: marked elevation of transaminases with possible jaundice.
• Allergic reactions: rash, pruritus, or angioedema.
• Myopathy with weakness: significant muscle weakness affecting daily activities.

When prescribing Lipus, clinicians should observe several safety measures.

• Baseline assessment: obtain liver function tests before initiating therapy.
• Monitoring: repeat liver enzymes periodically, especially after dose changes.
• Drug interactions: avoid concomitant use with strong CYP3A4 inhibitors.
• Pregnancy: contraindicated; do not prescribe to pregnant women (Category X).
• Lactation: discontinue if breastfeeding, as drug may be excreted in milk.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Lovastatin interacts with several medicines that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): can markedly increase lovastatin levels.
• Gemfibrozil: synergistic effect raises risk of myopathy.
• Antacids containing aluminum or magnesium: may reduce absorption of lovastatin.

Moderate Interactions (Monitor Closely)

• Grapefruit juice: can increase lovastatin concentration, monitor for muscle symptoms.
• Cyclosporine: may elevate statin levels, consider dose adjustment.
• Warfarin: may enhance anticoagulant effect, monitor INR.